Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 4, 2014
Grant Date -
Dec 23, 2010
app pub date -
Nov 24, 2008
filing date -
Dec 12, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
What is provided is EPO mimetic peptide derivatives defined as formula (I) and their pharmaceutical salts, the preparation thereof, wherein R1, R2, R3, R4, R5, n1, n2 are defined as described in description. A composition comprising of an EPO mimetic peptide derivative defined as formula (I) and its pharmaceutical salt. The uses of the derivatives and their pharmaceutical salts, as well as the uses of the compositions described above in treatment of diseases characterized by a deficiency of EPO or a low or defective red blood cell population.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully